CP1 0.00% 17.0¢ cannpal animal therapeutics limited

Ann: CannPal Completes Phase 1B Cannabinoid Study in Dogs, page-3

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 614 Posts.
    lightbulb Created with Sketch. 122
    Amazing! 5 times the dose for no adverse effects, this is big.. cp1 is not getting the attention they deserve
 
watchlist Created with Sketch. Add CP1 (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.